Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2011

Oct 14, 2011

34519_dirs_2011-10-14_c19ea349-1cdf-4deb-9a41-a12888c23358.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-10-12

Reporting Person: Kunde Bobbi Jo (Director of Sales and Marketin)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-10-12 Incentive Stock Option (Right to Buy) $5.75 A 5000 Acquired 2021-10-11 Common Stock (5000) Direct